Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

Similar articles for PubMed (Select 22169944)

1.

Cerebrospinal fluid biomarkers for major depression confirm relevance of associated pathophysiology.

Ditzen C, Tang N, Jastorff AM, Teplytska L, Yassouridis A, Maccarrone G, Uhr M, Bronisch T, Miller CA, Holsboer F, Turck CW.

Neuropsychopharmacology. 2012 Mar;37(4):1013-25. doi: 10.1038/npp.2011.285. Epub 2011 Dec 14.

2.

Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer's disease and non-demented elderly subjects.

Castaño EM, Roher AE, Esh CL, Kokjohn TA, Beach T.

Neurol Res. 2006 Mar;28(2):155-63.

PMID:
16551433
4.

Identification of novel biomarker candidates by proteomic analysis of cerebrospinal fluid from patients with moyamoya disease using SELDI-TOF-MS.

Araki Y, Yoshikawa K, Okamoto S, Sumitomo M, Maruwaka M, Wakabayashi T.

BMC Neurol. 2010 Nov 8;10:112. doi: 10.1186/1471-2377-10-112.

5.

Proteomic identification of potential protein markers in cerebrospinal fluid of GBS patients.

Jin T, Hu LS, Chang M, Wu J, Winblad B, Zhu J.

Eur J Neurol. 2007 May;14(5):563-8.

PMID:
17437617
6.

Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform.

Pan S, Rush J, Peskind ER, Galasko D, Chung K, Quinn J, Jankovic J, Leverenz JB, Zabetian C, Pan C, Wang Y, Oh JH, Gao J, Zhang J, Montine T, Zhang J.

J Proteome Res. 2008 Feb;7(2):720-30. doi: 10.1021/pr700630x. Epub 2008 Jan 11.

PMID:
18186601
8.

Proteome profiling of human cerebrospinal fluid: exploring the potential of capillary electrophoresis with surface modified capillaries for analysis of complex biological samples.

Zuberovic A, Hanrieder J, Hellman U, Bergquist J, Wetterhall M.

Eur J Mass Spectrom (Chichester, Eng). 2008;14(4):249-60. doi: 10.1255/ejms.929.

PMID:
18756023
9.

Identification of biomarkers for diagnosis and progression of MS by MALDI-TOF mass spectrometry.

Teunissen CE, Koel-Simmelink MJ, Pham TV, Knol JC, Khalil M, Trentini A, Killestein J, Nielsen J, Vrenken H, Popescu V, Dijkstra CD, Jimenez CR.

Mult Scler. 2011 Jul;17(7):838-50. doi: 10.1177/1352458511399614. Epub 2011 Apr 19.

PMID:
21505015
10.

Cerebrospinal fluid proteome profile in multiple sclerosis.

Lehmensiek V, Süssmuth SD, Tauscher G, Brettschneider J, Felk S, Gillardon F, Tumani H.

Mult Scler. 2007 Aug;13(7):840-9.

PMID:
17881397
11.

Proteome analysis of biomarkers in the cerebrospinal fluid of neuromyelitis optica patients.

Bai S, Liu S, Guo X, Qin Z, Wang B, Li X, Qin Y, Liu YH.

Mol Vis. 2009 Aug 19;15:1638-48.

12.

Principle component analysis combined with matrix-assisted laser desorption ionization mass spectrometry for rapid diagnosing the sera of patients with major depression.

Huang TL, Cho YT, Su H, Shiea J.

Clin Chim Acta. 2013 Sep 23;424:175-81. doi: 10.1016/j.cca.2013.06.003. Epub 2013 Jun 15.

PMID:
23778025
13.

The relationship between cerebrospinal fluid biomarkers and depression in elderly women.

Gudmundsson P, Skoog I, Waern M, Blennow K, Pálsson S, Rosengren L, Gustafson D.

Am J Geriatr Psychiatry. 2007 Oct;15(10):832-8.

PMID:
17911361
14.

Preliminary analysis of cerebrospinal fluid proteome in patients with neurocysticercosis.

Tian XJ, Li JY, Huang Y, Xue YP.

Chin Med J (Engl). 2009 May 5;122(9):1003-8.

PMID:
19493432
15.

Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples.

Freed GL, Cazares LH, Fichandler CE, Fuller TW, Sawyer CA, Stack BC Jr, Schraff S, Semmes OJ, Wadsworth JT, Drake RR.

Laryngoscope. 2008 Jan;118(1):61-8.

PMID:
18043497
16.
17.

Identification of proteomic signatures associated with lung cancer and COPD.

Pastor MD, Nogal A, Molina-Pinelo S, Meléndez R, Salinas A, González De la Peña M, Martín-Juan J, Corral J, García-Carbonero R, Carnero A, Paz-Ares L.

J Proteomics. 2013 Aug 26;89:227-37. doi: 10.1016/j.jprot.2013.04.037. Epub 2013 May 9.

PMID:
23665002
18.

Temporally resolved differential proteomic analysis of human ventricular CSF for monitoring traumatic brain injury biomarker candidates.

Hanrieder J, Wetterhall M, Enblad P, Hillered L, Bergquist J.

J Neurosci Methods. 2009 Mar 15;177(2):469-78.

PMID:
19263575
19.

Identification of tumor-related proteins by proteomic analysis of cerebrospinal fluid from patients with primary brain tumors.

Zheng PP, Luider TM, Pieters R, Avezaat CJ, van den Bent MJ, Sillevis Smitt PA, Kros JM.

J Neuropathol Exp Neurol. 2003 Aug;62(8):855-62.

PMID:
14503641
20.

A novel unbiased proteomic approach to detect the reactivity of cerebrospinal fluid in neurological diseases.

Menon KN, Steer DL, Short M, Petratos S, Smith I, Bernard CC.

Mol Cell Proteomics. 2011 Jun;10(6):M110.000042. doi: 10.1074/mcp.M110.000042. Epub 2011 Mar 18.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk